125 related articles for article (PubMed ID: 10579872)
1. Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis.
Shin BA; Kim YR; Lee IS; Sung CK; Hong J; Sim CJ; Im KS; Jung JH
J Nat Prod; 1999 Nov; 62(11):1554-7. PubMed ID: 10579872
[TBL] [Abstract][Full Text] [Related]
2. Additional bioactive Lyso-PAF congeners from the sponge Spirastrella abata.
Alam N; Bae BH; Hong J; Lee CO; Shin BA; Im KS; Jung JH
J Nat Prod; 2001 Apr; 64(4):533-5. PubMed ID: 11325244
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids.
Marathe GK; Silva AR; de Castro Faria Neto HC; Tjoelker LW; Prescott SM; Zimmerman GA; McIntyre TM
J Lipid Res; 2001 Sep; 42(9):1430-7. PubMed ID: 11518762
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of seven lyso platelet-activating factors and two lyso phosphatidylcholines from the crude drug "suitetsu" (the leech, Hirudo nipponica).
Noda N; Tanaka R; Nishi M; Inoue S; Miyahara K
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1366-8. PubMed ID: 8403084
[TBL] [Abstract][Full Text] [Related]
5. New lysophosphatidylcholines and monoglycerides from the marine sponge Stelletta sp.
Zhao Q; Mansoor TA; Hong J; Lee CO; Im KS; Lee DS; Jung JH
J Nat Prod; 2003 May; 66(5):725-8. PubMed ID: 12762820
[TBL] [Abstract][Full Text] [Related]
6. Effects of platelet-activating factor (PAF), lyso-PAF and lysophosphatidylcholine on phosphatidylcholine bilayers, an ESR, 31P-NMR and X-ray diffraction study.
Olivier JL; Chachaty C; Quinn PJ; Wolf C
J Lipid Mediat; 1991; 3(3):311-32. PubMed ID: 1663404
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor and lyso-phosphatidylcholines from strawberry.
Calligerou M; Siafaka-Kapadai A; Galanopoulou D; Weintraub ST; Mavri-Vavayanni M
Phytochemistry; 1996 Jan; 41(1):89-92. PubMed ID: 8588879
[TBL] [Abstract][Full Text] [Related]
8. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
[TBL] [Abstract][Full Text] [Related]
9. Structural determination of lysophosphatidylcholines extracted from marine sponges by fast atom bombardment tandem mass spectrometry.
Hong J; Cho K; Kim YH; Cheong C; Lee KS; Jung JH
Rapid Commun Mass Spectrom; 2001; 15(13):1120-6. PubMed ID: 11404849
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro.
Steel HC; Cockeran R; Anderson R
APMIS; 2002 Feb; 110(2):158-64. PubMed ID: 12064871
[TBL] [Abstract][Full Text] [Related]
11. [HMG-CoA reductase inhibitors].
Endo A
Nihon Rinsho; 1991 Sep; 49(9):2004-9. PubMed ID: 1960868
[No Abstract] [Full Text] [Related]
12. Hypocholesterolemic agents.
Endo A
Biotechnology; 1994; 26():301-20. PubMed ID: 7749309
[No Abstract] [Full Text] [Related]
13. A gift from nature: the birth of the statins.
Endo A
Nat Med; 2008 Oct; 14(10):1050-2. PubMed ID: 18841147
[No Abstract] [Full Text] [Related]
14. Synthesis of a novel lysophosphatidylcholine.
Zhu C; Morimoto T; Nakajima S; Nitoda T; Baba N
J Nat Prod; 2001 Jan; 64(1):98-9. PubMed ID: 11170677
[TBL] [Abstract][Full Text] [Related]
15. The formation and secretion of cholesteryl esters in rat hepatocytes are reduced by lovastatin and simvastatin.
MartÃnez MJ; Hernández ML; Isusi E; Aspichueta P; Ochoa B
Biochem Soc Trans; 1998 Feb; 26(1):S82. PubMed ID: 10909840
[No Abstract] [Full Text] [Related]
16. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.
Komoda Y; Shimizu M; Sonoda Y; Sato Y
Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):531-3. PubMed ID: 2743504
[TBL] [Abstract][Full Text] [Related]
17. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet-activating factor, lyso-platelet-activating factor, and lysophosphatidylcholine on sperm motion: importance of albumin for motility stimulation.
Jarvi K; Roberts KD; Langlais J; Gagnon C
Fertil Steril; 1993 Jun; 59(6):1266-75. PubMed ID: 8495776
[TBL] [Abstract][Full Text] [Related]
19. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
[TBL] [Abstract][Full Text] [Related]
20. Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF.
Oliver JL; Chachaty C; Wolf C; Bereziat G
Agents Actions; 1989 Jan; 26(1-2):121-2. PubMed ID: 2711930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
